Efficacy and safety of amino acid-based formulas in the management of infants with cow’s milk protein allergy: an open-label prospective controlled study
Open Access
- 23 July 2026
- journal article
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (2) , 73-83
Abstract
Aim. To determine the efficacy and safety of long-term use of an amino acid-based formula in children with cow›s milk protein allergy (CMPA) and moderate to severe atopic dermatitis (AD). Materials and methods. The study included 60 children under 12 months of age with CMPA presenting with cutaneous symptoms (moderate or severe AD according to the oSCORAD) and/or gastrointestinal symptoms. Prior to the study, all patients were prescribed an extensively hydrolyzed formula (EHF) for 4 weeks. Patients with no or incomplete response to EHF ( n = 30) were assigned to Group 1, receiving an amino acid-based formula (AAF) for 12 months. The 30 patients who showed a positive response to EHF were assigned to Group 2. Results. Children in Group 1 showed greater gains in weight and height during the first 6 months compared to children in Group 2 ( p < 0.001). The resolution of gastrointestinal symptoms in children receiving AAF was observed within 14 days along with an improvement in the clinical picture of AD within 3–5 days. Also, both groups showed a decrease in oSCORAD and EASI scores; however, children receiving AAF had a significantly smaller number of exacerbations ( p = 0.041) and a lower impact of dermatosis on daily activities ( p = 0.002). After 6 months of therapy, 53.3% of children in Group 1 developed tolerance to cow’s milk proteins, compared to only 23.3% in Group 2 ( p = 0.017). After 2 years of follow-up, tolerance was noted in all children who received AAF versus 87.7% of those fed with EHF. Conclusion. The use of AAF in children with CMPA is an effective dietary management method that leads to faster resolution of gastrointestinal symptoms, improvement in the course of atopic dermatitis, and prolongation of its remission. It shortens the period for tolerance development, has a positive effect on the child›s physical development, and contributes to a significant improvement in the quality of life of both patients and their parents.Keywords
This publication has 13 references indexed in Scilit:
- A Comparison of Amino Acid-Based, Hydrolyzed, and Soy-Based Formulas on Growth of Pediatric Patients with Cow’s Milk Allergy: A Systematic Review and Meta-Analysis of Clinical TrialsBreastfeeding Medicine, 2025
- Key factors that influence quality of life in patients with IgE ‐mediated food allergy vary by ageAllergy, 2024
- Epidemiology and the Growing Epidemic of Food Allergy in Children and Adults Across the GlobeCurrent Allergy and Asthma Reports, 2024
- World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's milk allergyWorld Allergy Organization Journal, 2023
- The use of amino acid formulas in pediatric patients with allergy to cow’s milk proteins: Recommendations from a group of expertsFrontiers in Pediatrics, 2023
- Recent developments and highlights in food allergyAllergy, 2019
- Influences of Maternal Factors Over Offspring Allergies and the Application for Food AllergyFrontiers in Immunology, 2019
- The Association of the Delayed Introduction of Cow's Milk with IgE-Mediated Cow's Milk AllergiesThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- Food intolerance and allergyCurrent Opinion in Clinical Nutrition and Metabolic Care, 2014
- Diagnostic Approach and Management of Cow's‐Milk Protein Allergy in Infants and ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2012